Patent: 10,092,706

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 10,092,706

Title:	Autoinjector apparatus
Abstract:	An autoinjector apparatus is disclosed which comprises a single-use cassette and an autoinjector. The cassette comprises a housing and a sleeve movably disposed in the housing. A syringe may be disposed in the sleeve and secured therein with a lock cap. The lock cap is affixed to a distal end of the sleeve and contacts the distal end of the syringe. A shield remover extends through an opening in a proximal end of the housing for removing a needle shield which covers a needle of the syringe. A cassette identification arrangement is provided on a surface of the housing to enable the autoinjector to identify the cassette. The autoinjector is provided with a detector for reading the cassette identification arrangement.
Inventor(s):	Denzer; Michael (Ringoes, NJ), Swift; Robert W. (Fillmore, CA), Johnston; Neal D. (Dallas, TX), Ganzitti; Gabriele (Milan, IT), Ewing; Kenneth R. (Fremont, CA), Krishna; Suhas (Simi Valley, CA)
Assignee:	AMGEN INC. (Thousand Oaks, CA)
Application Number:	14/112,479
Patent Claims:	see list of patent claims

Details for Patent 10,092,706

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	REMICADE	infliximab	For Injection	103772	08/24/1998	See Plans and Pricing	2031-04-20
Immunex Corporation	ENBREL	etanercept	For Injection	103795	11/02/1998	See Plans and Pricing	2031-04-20
Immunex Corporation	ENBREL	etanercept	For Injection	103795	05/27/1999	See Plans and Pricing	2031-04-20
Immunex Corporation	ENBREL	etanercept	Injection	103795	09/27/2004	See Plans and Pricing	2031-04-20
Immunex Corporation	ENBREL	etanercept	Injection	103795	02/01/2007	See Plans and Pricing	2031-04-20
Immunex Corporation	ENBREL MINI	etanercept	Injection	103795	09/14/2017	See Plans and Pricing	2031-04-20
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.